SCHEMBL21628784

SCHEMBL21628784

CNC(=O)c1cnc(Oc2ccc(C3CCCCCC3)cc2)c(F)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 2/20 0.45
HRH3 Q9Y5N1 2/20 0.41
STAT3 P40763 1/20 0.40
NAMPT P43490 1/20 0.40
DEGS1 O15121 1/20 0.40
HPGDS O60760 3/20 0.40
S1PR2 O95136 1/20 0.40
CSF1R P07333 1/20 0.39
FAAH O00519 2/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HAO1 Q9UJM8 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
PROKR1 Q8TCW9 1/20 0.38
CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21628435 1.00 SCN9A (0.45) SCN9AHRH3STAT3NAMPTDEGS1
SCHEMBL21628704 0.99 SCN9A (0.45) SCN9AHRH3STAT3NAMPTDEGS1
SCHEMBL21656946 0.97 SCN9A (0.43) SCN9AHRH3STAT3NAMPTHPGDS
SCHEMBL21628762 0.94 CSF1R (0.43) SCN9AHRH3HPGDSCSF1RHPGD
SCHEMBL20482263 0.90 HDAC6 (0.51) STAT3NAMPTDEGS1HPGDSHAO1
SCHEMBL21628663 0.90 HDAC6 (0.51) STAT3NAMPTDEGS1HPGDSHAO1
SCHEMBL21628739 0.89 HDAC6 (0.52) STAT3NAMPTDEGS1HAO1HDAC1
SCHEMBL21628488 0.88 SMN1; SMN2 (0.42) STAT3NAMPTDEGS1HPGDSHTT
SCHEMBL21628383 0.88 SMN1; SMN2 (0.42) STAT3NAMPTDEGS1HPGDSHTT
SCHEMBL21628889 0.86 KMT2A (0.45) STAT3NAMPTDEGS1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-12-21 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2022-11-03 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK SCN9A 4485/4885HRH3 69/4885STAT3 441/4885
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK SCN9A 4485/4885HRH3 69/4885STAT3 441/4885
US-11591289-B2 Aromatic compounds AHR, TYR, MUSK SCN9A 4603/4885HRH3 60/4885STAT3 416/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK SCN9A 4485/4885HRH3 69/4885STAT3 441/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR SCN9A 3257/4885HRH3 92/4885STAT3 2711/4885
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK SCN9A 4485/4885HRH3 69/4885STAT3 441/4885
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK SCN9A 4485/4885HRH3 69/4885STAT3 441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.